313 related articles for article (PubMed ID: 19446839)
1. Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report.
Cagli KE; Guray U; Akpinar I; Sen N; Aras D; Topaloglu S
J Electrocardiol; 2010; 43(1):68-70. PubMed ID: 19446839
[TBL] [Abstract][Full Text] [Related]
2. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
Moore DR; Kok LC; Vijayaraman P
J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
[No Abstract] [Full Text] [Related]
3. Ventricular tachyarrhythmia induction by strong cardiac shocks: can understanding underlying mechanisms lead to improved prevention of defibrillator failure?
Nattel S
Heart Rhythm; 2006 May; 3(5):596-7. PubMed ID: 16648067
[No Abstract] [Full Text] [Related]
4. Shocking truths about implantable cardioverter defibrillator monitoring zones.
Mansour F; Thibault B; Dubuc M; Guerra PG; Macle L; Brugada R; Roy D; Talajic M; Khairy P
Pacing Clin Electrophysiol; 2007 Sep; 30(9):1146-8. PubMed ID: 17725760
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Recurrent Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators-A Network Meta-analysis.
Malik AH; Aronow WS
Am J Ther; 2019; 26(4):e469-e480. PubMed ID: 30946044
[TBL] [Abstract][Full Text] [Related]
7. Programming implantable cardioverter-defibrillators in primary prevention: higher or later.
Clementy N; Pierre B; Simeon E; Lallemand B; Fauchier L; Babuty D
Arch Cardiovasc Dis; 2014 May; 107(5):308-18. PubMed ID: 24834904
[TBL] [Abstract][Full Text] [Related]
8. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator.
Chinushi M; Aizawa Y; Higuchi K
Heart; 1997 Apr; 77(4):373-4. PubMed ID: 9155621
[TBL] [Abstract][Full Text] [Related]
9. Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Jacquemart C; Ould Abderrahmane F; Massin MM
J Electrocardiol; 2012; 45(6):736-8. PubMed ID: 22672791
[TBL] [Abstract][Full Text] [Related]
10. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
Francisco GM; Sharma S; Dougherty AH; Kantharia BK
Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
[TBL] [Abstract][Full Text] [Related]
11. Cardiac transplantation in a patient with emotionally triggered implantable cardioverter defibrillator storms.
Parsai C; Bonvini RF; Schnetzler B; Sunthorn H
Heart Vessels; 2007 Sep; 22(5):349-51. PubMed ID: 17879028
[TBL] [Abstract][Full Text] [Related]
12. Termination of ventricular tachycardia by far-field stimulation in humans: a feasibility study.
Lawo T; Schrader J; Buddensiek M; Schweika O; Mügge A; Bösche LI
Pacing Clin Electrophysiol; 2010 Dec; 33(12):1540-7. PubMed ID: 21039638
[TBL] [Abstract][Full Text] [Related]
13. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism?
Vollmann D; Lüthje L; Zabel M
Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370
[No Abstract] [Full Text] [Related]
14. Implantable cardioverter-defibrillator shocks in dying patients: disturbing data from beyond the grave.
Lampert R
Circulation; 2014 Jan; 129(4):414-6. PubMed ID: 24243856
[No Abstract] [Full Text] [Related]
15. Phantom shock in a patient with an implantable cardioverter defibrillator: case report.
Prudente LA
Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172
[No Abstract] [Full Text] [Related]
16. Potential proarrhythmic effects of implantable cardioverter-defibrillators.
Duru F; Candinas R
Clin Cardiol; 1999 Feb; 22(2):139-46. PubMed ID: 10068856
[TBL] [Abstract][Full Text] [Related]
17. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
18. Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.
Bradfield J; Tung R; Boyle NG; Shivkumar K
Heart Fail Rev; 2011 Sep; 16(5):449-56. PubMed ID: 21451976
[TBL] [Abstract][Full Text] [Related]
19. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
Kuck KH
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
[No Abstract] [Full Text] [Related]
20. Ventricular arrhythmias in patients with implanted cardioverter defibrillators.
John RM; Stevenson WG
Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
